Activation of protein kinase C increases adenosine production in the hypoxic canine coronary artery through the extracellular pathway

Arterioscler Thromb Vasc Biol. 1995 Dec;15(12):2298-304. doi: 10.1161/01.atv.15.12.2298.

Abstract

Both ischemia and hypoxia increase adenosine production in the heart. This study tested whether hypoxia increases adenosine production in the coronary artery via ecto-5'-nucleotidase and the role of protein kinase C in this condition. Canine left circumflex coronary artery was rapidly removed and incubated in 10 mL Krebs-Henseleit solution for 30 minutes. The Krebs-Henseleit solution contained 5'-iodotubercidin and 2'-deoxycoformycin, which inhibit adenosine kinase and adenosine deaminase, respectively. Adenosine production was measured in intact coronary arteries under normoxic conditions (16.2 +/- 1.2 pmol/mg protein). Adenosine production was reduced by 27% after removal of endothelium. Ecto-5'-nucleotidase activity of coronary arteries with and without endothelium was 51 +/- 6 and 41 +/- 4 nmol/mg protein per minute under normoxic conditions. Hypoxia increased adenosine production to 27.0 +/- 2.3 and 20.0 +/- 0.8 pmol/mg protein with and without endothelium. Hypoxia also increased ecto-5'-nucleotidase activity of coronary arteries with and without endothelium (74 +/- 8 and 53 +/- 5 nmol/mg protein per minute; P < .05). Increases in adenosine production under hypoxic conditions were blunted by both an inhibitor of ecto-5'-nucleotidase and inhibitors of protein kinase C. Activation of ecto-5'-nucleotidase was blunted by an inhibitor of protein kinase C. These results indicate that hypoxia increased extracellular adenosine production and activated ecto-5'-nucleotidase via activation of protein kinase C in coronary arterial smooth muscle and endothelial cells. Increased adenosine production in coronary arteries during hypoxia may contribute to coronary vasodilation and cardioprotection against ischemic injury.

MeSH terms

  • 5'-Nucleotidase / metabolism
  • Adenosine / biosynthesis*
  • Adenosine Deaminase Inhibitors
  • Adenosine Kinase / antagonists & inhibitors
  • Animals
  • Arteries / metabolism
  • Coronary Vessels / metabolism*
  • Dogs
  • Enzyme Activation
  • Hypoxia / metabolism*
  • In Vitro Techniques
  • Pentostatin / pharmacology
  • Protein Kinase C / metabolism*
  • Tubercidin / analogs & derivatives
  • Tubercidin / pharmacology

Substances

  • Adenosine Deaminase Inhibitors
  • 5-iodotubercidin
  • Pentostatin
  • Adenosine Kinase
  • Protein Kinase C
  • 5'-Nucleotidase
  • Adenosine
  • Tubercidin